The data shows a steady increase in hospital discharges for dermatitis, eczema, and papulosquamous disorders in France from 2024 to 2028, with values rising from 13.44 to 13.71 thousand. In 2023, the cases stood at 13.37 thousand, indicating a minor year-on-year growth rate. The annual increase in discharges is small but consistent. Over the five-year period, the compound annual growth rate (CAGR) reflects a stable upward trajectory in hospital discharges.
Future trends to watch for include advances in dermatological treatments that could reduce hospitalizations, shifts in environmental factors impacting these conditions, and healthcare policy changes affecting admission processes. Monitoring these elements will provide insights into potential fluctuations in future discharge rates.
